Stockreport

Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why [Yahoo! Finance]

Instil Bio, Inc.  (TIL) 
NASDAQ:AMEX Investor Relations: nasdaq.com/symbol/til
PDF Instil is engaged in developing tumor infiltrating lymphocyte, or TIL, therapies targeting multiple cancer indications. Earlier this week, the company entered into an [Read more]